MAPT and early-onset autosomal dominant Alzheimer disease: In neurodegenerative disorders such as Alzheimer’s disease (AD), the methylation of the tau protein has been found to affect its aggregation and toxicity and showed as a crucial controller of tau aggregation and neuronal health [54,55].